织梦CMS - 轻松建站从此开始!

欧博ABG官网-欧博官方网址-会员登入

Topo欧博注册tecan Hydrochloride

时间:2025-08-20 20:14来源: 作者:admin 点击: 3 次
Topotecan hydrochloride is a chemotherapy drug that damages the DNA of cancer cells and other rapidly growing cells, causing them to die.

FDA label information for this drug is available at DailyMed.

Use in Cancer

Topotecan hydrochloride is approved to be used alone or with other drugs to treat:

Topotecan hydrochloride is also being studied in the treatment of other types of cancer.

More About Topotecan Hydrochloride

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

MedlinePlus Information on Topotecan Hydrochloride - A lay language summary of important information about this drug that may include the following:

warnings about this drug,

what this drug is used for and how it is used,

what you should tell your doctor before using this drug,

what you should know about this drug before using it,

other drugs that may interact with this drug, and

possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials Accepting Patients

Find Clinical Trials for Topotecan Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.

(责任编辑:)
------分隔线----------------------------
发表评论
请自觉遵守互联网相关的政策法规,严禁发布色情、暴力、反动的言论。
评价:
表情:
用户名: 验证码:
发布者资料
查看详细资料 发送留言 加为好友 用户等级: 注册时间:2025-08-23 19:08 最后登录:2025-08-23 19:08
栏目列表
推荐内容